Cohen Fred E — SEC Form 4 filings
SEC reporting owner CIK 1339358. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-14 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 150,000 shares, $1,402,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: purchase of 150,000 shares @ $9.35 ($1,402,500) in Intellia Therapeutics, Inc., filed 2026-01-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | Director | 4 | 1 leg · 150,000 sh · $1,402,500 | — | 6 |
| Kyverna Therapeutics, Inc. (KYTX) | Director | 3 | — | — | 8 |
| CareDx, Inc. (CDNA) | Director | 4 | — | — | 5 |
| Progyny, Inc. (PGNY) | Director | 1 | — | — | 2 |
| UroGen Pharma Ltd. (URGN) | Director | 1 | — | — | 1 |
Form 4 filings — Cohen Fred E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 9,795 @ $0 | EDGAR |
| 2026-06-10 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 9,200 @ $0 · Grant/award (A): 13,300 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Kyverna Therapeutics, Inc. (KYTX) | Grant/award (A): 5,093 @ $0 · Grant/award (A): 20,582 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Intellia Therapeutics, Inc. (NTLA) | Purchase (P): 150,000 @ $9.35 | EDGAR |
| 2025-06-17 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 12,103 @ $0 | EDGAR |
| 2025-06-13 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 11,450 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Kyverna Therapeutics, Inc. (KYTX) | Grant/award (A): 16,634 @ $0 · Grant/award (A): 65,351 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4/A | CareDx, Inc. (CDNA) | Grant/award (A): 16,048 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 10,570 @ $0 · Grant/award (A): 16,048 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 7,737 @ $0 · Grant/award (A): 11,515 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Progyny, Inc. (PGNY) | Grant/award (A): 6,176 @ $0 · Grant/award (A): 25,070 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Kyverna Therapeutics, Inc. (KYTX) | Conversion (C): 4,523,924 · Conversion (C): 4,401,771 (derivative) @ $0 · Conversion (C): 8,830,901 (derivative) @ $0 · Conversion (C): 7,356,162 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1339358 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →